Acarregui Argia, Orive Gorka, Pedraz José Luis, Hernández Rosa María
NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.
Methods Mol Biol. 2013;1051:349-64. doi: 10.1007/978-1-62703-550-7_23.
The synergy of some promising advances in the fields of cell therapy and biomaterials together with improvements in the fabrication of more refined and tailored microcapsules for drug delivery have triggered the progress of cell encapsulation technology. Cell microencapsulation involves immobilizing the transplanted cells within a biocompatible scaffold surrounded by a membrane in attempt to isolate the cells from the host immune attack and enhance or prolong their function in vivo. This technology represents one strategy which aims to overcome the present difficulties related to local and systemic controlled release of drugs and growth factors as well as to organ graft rejection and thus the requirements for use of immunomodulatory protocols or immunosuppressive drugs. This chapter gives an overview of the current situation of cell encapsulation technology as a controlled drug delivery system, and the essential requirements of the technology, some of the therapeutic applications, the challenges, and the future directions under investigation are highlighted.
细胞治疗和生物材料领域一些有前景的进展,以及用于药物递送的更精细、定制化微胶囊制造技术的改进,共同推动了细胞封装技术的进步。细胞微封装是将移植的细胞固定在由膜包围的生物相容性支架内,试图使细胞免受宿主免疫攻击,并增强或延长其在体内的功能。这项技术是一种策略,旨在克服目前与药物和生长因子的局部和全身控释以及器官移植排斥相关的困难,从而减少对免疫调节方案或免疫抑制药物的需求。本章概述了作为一种控释药物递送系统的细胞封装技术的现状,强调了该技术的基本要求、一些治疗应用、挑战以及正在研究的未来方向。